To further validate the clinical relevance of our findings, we analyzed a tissue microarray (TMA) comprising 111 tumor samples from melanoma patients to assess the expression of SLC25A1, ACLY, and FSP1 using multiplex immunofluorescence (mIF) staining. This evidence concerns the gene AIFM2 and neoplasm.